Found 17 matching trials
Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting
PHASE2Test the safety, immune response and efficacy of GVAX pancreas vaccine (wit...
Location
Scottsdale Healthcare Research Institute
Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer
PHASE2The purpose of this study is to evaluate the safety and feasibility of long...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer
PHASE2The purpose of this study is to evaluate the safety and clinical activity o...
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
PHASE2This platform trial will evaluate various immunotherapy combinations given ...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
PHASE2RATIONALE: Vaccines made from gene-modified tumor cells may help the body b...
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer
PHASE1The purpose of this study is to determine the optimal dose of AGEN2373 that...
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas
PHASE2The purpose of this study is to estimate safety of GVAX Pancreas Vaccine (G...
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer
PHASE2This study will be looking at whether combining cyclophosphamide, pembroliz...
Location
The Sidney Kimmel Comprehensive Cancer at Johns Hopkins
Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer
PHASE2This study will enroll patients who have metastatic pancreatic cancer and h...
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
EARLY_PHASE1The purpose of this study is to evaluate whether combining cyclophosphamide...
Location
Sidney Kimmel Comprehensive Cancer Center